Handelsbanken Fonder AB Purchases 95,000 Shares of Merit Medical Systems, Inc. $MMSI

Handelsbanken Fonder AB lifted its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 42.0% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 321,309 shares of the medical instruments supplier’s stock after buying an additional 95,000 shares during the period. Handelsbanken Fonder AB’s holdings in Merit Medical Systems were worth $26,743,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Salomon & Ludwin LLC purchased a new position in Merit Medical Systems in the third quarter worth $37,000. First Horizon Corp purchased a new stake in shares of Merit Medical Systems during the 3rd quarter valued at $78,000. EverSource Wealth Advisors LLC raised its stake in shares of Merit Medical Systems by 745.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock worth $86,000 after purchasing an additional 813 shares during the period. Palouse Capital Management Inc. boosted its holdings in shares of Merit Medical Systems by 27.5% in the 3rd quarter. Palouse Capital Management Inc. now owns 1,076 shares of the medical instruments supplier’s stock worth $90,000 after buying an additional 232 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its position in Merit Medical Systems by 28.7% during the third quarter. Smartleaf Asset Management LLC now owns 1,663 shares of the medical instruments supplier’s stock valued at $134,000 after buying an additional 371 shares during the period. 99.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MMSI has been the topic of several research reports. Barrington Research lifted their price objective on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research report on Wednesday. Wells Fargo & Company cut shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $95.00 to $78.00 in a report on Thursday. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Zacks Research downgraded Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Piper Sandler lowered their target price on Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Merit Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $103.33.

Merit Medical Systems Price Performance

MMSI stock opened at $77.18 on Friday. The firm has a 50 day moving average of $83.52 and a 200-day moving average of $84.85. The firm has a market capitalization of $4.59 billion, a P/E ratio of 36.41, a price-to-earnings-growth ratio of 2.26 and a beta of 0.61. Merit Medical Systems, Inc. has a 12 month low of $76.68 and a 12 month high of $107.27. The company has a current ratio of 4.34, a quick ratio of 2.86 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. During the same quarter in the prior year, the firm posted $0.93 EPS. Merit Medical Systems’s revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, sell-side analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.